Clinical Trial Update: CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CD19-directed CAR T cell therapy for pediatric, adolescent, and young adult patients with CD19-positive acute lymphoblastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-directed CAR-T cell therapy

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING